Old Web
English
Sign In
Acemap
>
authorDetail
>
De Vita Ferdinando
De Vita Ferdinando
HCT116 Cell
Cancer research
IC50
Erlotinib
Gefitinib
1
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
IC50 for treatment with erlotinib, gefitinib or vandetanib in parental CALU-3 and HCT116 cell lines (WT) and their TKI-resistant derivatives (ERL-R, GEF-R, VAN-R).
2013
PLOS ONE
Morgillo Floriana
Martinelli Erika
Troiani Teresa
Orditura Michele
De Vita Ferdinando
Ciardiello Fortunato
Show All
Source
Cite
Save
Citations (0)
1